Cover Feature: How Clavulanic Acid Inhibits Serine β‐Lactamases (ChemBioChem 22/2024)
Clavulanic acid is a densely functionalized low mass (C8H9NO5) drug, which is used to protect penicillins and other β-lactam antibiotics from hydrolysis by serine β-lactamases. As shown by detailed mass spectrometric analyses, clavulanic acid reacts covalently with serine β-lactamase to form an initial acyl-enzyme complex which, like the analogous complex formed with β-lactam antibiotics, can undergo hydrolysis. In the case of clavulanic acid, however, the acyl-enzyme complex also undergoes competing fragmentation to give inhibitory complexes stable to hydrolysis. More details can be found in article 10.1002/cbic.202400280 by Christopher J. Schofield and co-workers.
Authors
- Carol V. Robinson (ORCID: https://orcid.org/0000-0001-7829-5505)
- Timothy D. W. Claridge (ORCID: https://orcid.org/0000-0001-5583-6460)
- Christopher John Schofield (ORCID: https://orcid.org/0000-0002-0290-6565)
- Abraham Olusegun Oluwole (ORCID: https://orcid.org/0000-0001-8647-4781)
- Pauline A. Lang (ORCID: https://orcid.org/0000-0003-3187-1469)
- Mariska de Munnik (ORCID: https://orcid.org/0000-0003-0350-395X)
- Jürgen Brem (ORCID: https://orcid.org/0000-0002-0137-3226)
Institutions
- Babeș-Bolyai University (RO)
- University of Oxford (GB)
Publication Details
- Journal
- ChemBioChem
- Published
- 2024-11-18
- DOI
- https://doi.org/10.1002/cbic.202482202
- Primary Topic
- Medicinal plant effects and applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00